Veru VERU
NASDAQ VERU
$2.62 +0.04 (+1.65%)
As of: Aug 21, 2026 · 9:39 AM EDT

Veru (VERU) Work In Process (2018 - 2024)

Veru (VERU) posted quarterly Work In Process of $50484.0 for Q2 2024, down 33.44% year-over-year from $75848.0 in Q3 2023, and up 0.98% quarter-over-quarter from $49995.0 in Q1 2024.

Veru (VERU) Work In Process (2018 - 2024) Analysis & Trends

Veru (VERU) has reported Work In Process for 7 consecutive years, with $50484.0 the latest figure, recorded in Q2 2024.

  • In Q2 2024, Work In Process fell 33.44% year-over-year to $50484.0; the TTM figure through Jun 2024 stood at $50484.0 (down 33.44% YoY), while the FY2023 annual figure was $112799.0, down 87.07% from the prior year.
  • Work In Process grew to $50484.0 in Q2 2024 per VERU's latest filing, from $49995.0 in the prior quarter.
  • Across five years, Work In Process topped out at $872596.0 in Q3 2022 and bottomed at $38252.0 in Q4 2023.
  • Historically, Work In Process has averaged $218377.1 across 5 years, with a median of $83215.5 in 2021.
  • Annual changes were most pronounced in 2022 — Work In Process jumped 1286.52% — and 2023, when it tumbled 95.01%.
  • Veru's Work In Process stood at $63075.0 in 2020, then retreated by 12.35% to $55285.0 in 2021, then surged by 1286.52% to $766538.0 in 2022, then sank by 95.01% to $38252.0 in 2023, then soared by 31.98% to $50484.0 in 2024.
  • Business Quant data shows VERU's Work In Process at $50484.0 in Q2 2024, $49995.0 in Q1 2024, and $38252.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.41 Bn 130.56 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.12 Bn 78.12 Bn 3.93 Bn
3 Argenx Se 64.41 Bn 59.23 Bn 1.37 Bn
4 Moderna 57.56 Bn 52.43 Bn 52.00 Mn
5 BeOne Medicines 42.06 Bn 36.96 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.95 Bn 27.65 Bn 992.69 Mn
7 BioNTech SE 27.48 Bn 9.09 Bn 668.28 Mn
8 Insmed 27.31 Bn 26.15 Bn 358.27 Mn
9 Royalty Pharma 27.04 Bn 26.20 Bn -
10 Veru 60.39 Mn 34.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 50,484.00
Mar 31, 2024 49,995.00
Dec 31, 2023 38,252.00
Sep 30, 2023 112,799.00
Jun 30, 2023 75,848.00
Mar 31, 2023 715,480.00
Dec 31, 2022 766,538.00
Sep 30, 2022 872,596.00
Jun 30, 2022 54,004.00
Mar 31, 2022 544,859.00
Dec 31, 2021 55,285.00
Sep 30, 2021 112,915.00
Jun 30, 2021 90,583.00
Mar 31, 2021 44,425.00
Dec 31, 2020 63,075.00
Sep 30, 2020 106,272.00
Jun 30, 2020 127,693.00
Mar 31, 2020 49,684.00
Dec 31, 2019 60,358.00
Sep 30, 2019 187,970.00